Beyondspring Inc BYSI:NASDAQ

RT Quote | Last NASDAQ LS, VOL From CTA | USD
Last | 03/28/24 EDT
3.57UNCH (UNCH)
Volume
155,087
52 week range
0.65 - 4.00
Loading...
  • Open3.61
  • Day High3.61
  • Day Low3.32
  • Prev Close3.63
  • 52 Week High4.00
  • 52 Week High Date03/06/24
  • 52 Week Low0.65
  • 52 Week Low Date10/10/23

Key Stats

  • Market Cap138.959M
  • Shares Out38.92M
  • 10 Day Average Volume0.21M
  • Dividend-
  • Dividend Yield-
  • Beta0.14
  • YTD % Change296.67

KEY STATS

  • Open3.61
  • Day High3.61
  • Day Low3.32
  • Prev Close3.63
  • 52 Week High4.00
  • 52 Week High Date03/06/24
  • 52 Week Low0.65
  • 52 Week Low Date10/10/23
  • Market Cap138.959M
  • Shares Out38.92M
  • 10 Day Average Volume0.21M
  • Dividend-
  • Dividend Yield-
  • Beta0.14
  • YTD % Change296.67

RATIOS/PROFITABILITY

  • EPS (TTM)-0.85
  • P/E (TTM)-4.19
  • Fwd P/E (NTM)-1.23
  • EBITDA (TTM)-29.915M
  • ROE (TTM)-321.46%
  • Revenue (TTM)1.55M
  • Gross Margin (TTM)-
  • Net Margin (TTM)-1,895.29%
  • Debt To Equity (MRQ)-

EVENTS

  • Earnings Date-
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Beyondspring Inc

 

Profile

MORE
BeyondSpring Inc. is a clinical-stage global biopharmaceutical company. The Company is focused on using its technology platform for drug discovery and the development of therapies to improve clinical outcomes for patients with high unmet medical needs. The Company operates through two segments: the Plinabulin pipeline and Targeted Protein Degradation (TPD) platform. Plinabulin is being developed as a pipeline in a drug in various cancer indications as a direct anti-cancer...
Lan Huang Ph.D.
Chairperson of the Board, Chief Executive Officer, Co-Founder
Address
100 Campus Drive
West Side, 4Th Floor, Suite 410
Florham Park, NJ
07932
United States

Top Peers

SYMBOLLASTCHG%CHG
ANVS
Annovis Bio Inc
11.90UNCHUNCH
IMUX
Immunic Inc
1.32UNCHUNCH
ALLK
Allakos Inc
1.26UNCHUNCH
KNTE
Kinnate Biopharma Inc
2.66UNCHUNCH
CTXR
Citius Pharmaceuticals Inc
0.8973UNCHUNCH